A detailed history of Patriot Financial Group Insurance Agency, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Patriot Financial Group Insurance Agency, LLC holds 3,384 shares of VRTX stock, worth $1.38 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
3,384
Previous 3,082 9.8%
Holding current value
$1.38 Million
Previous $1.44 Million 8.93%
% of portfolio
0.22%
Previous 0.22%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$460.0 - $505.78 $138,920 - $152,745
302 Added 9.8%
3,384 $1.57 Million
Q2 2024

Jul 26, 2024

BUY
$392.81 - $485.53 $14,533 - $17,964
37 Added 1.22%
3,082 $1.44 Million
Q1 2024

Apr 30, 2024

BUY
$407.69 - $446.08 $30,576 - $33,456
75 Added 2.53%
3,045 $1.27 Million
Q4 2023

Jan 19, 2024

SELL
$343.0 - $410.68 $10,290 - $12,320
-30 Reduced 1.0%
2,970 $1.21 Million
Q3 2023

Oct 19, 2023

SELL
$338.18 - $362.46 $3,043 - $3,262
-9 Reduced 0.3%
3,000 $1.04 Million
Q2 2023

Jul 17, 2023

SELL
$314.42 - $351.91 $53,136 - $59,472
-169 Reduced 5.32%
3,009 $1.06 Million
Q1 2023

Apr 20, 2023

BUY
$283.23 - $323.1 $17,843 - $20,355
63 Added 2.02%
3,178 $1 Million
Q4 2022

Jan 17, 2023

SELL
$285.76 - $321.48 $15,716 - $17,681
-55 Reduced 1.74%
3,115 $0
Q3 2022

Oct 31, 2022

BUY
$273.83 - $305.53 $40,526 - $45,218
148 Added 4.9%
3,170 $918,000
Q2 2022

Jul 29, 2022

SELL
$234.96 - $292.55 $72,602 - $90,397
-309 Reduced 9.28%
3,022 $852,000
Q1 2022

May 11, 2022

BUY
$221.42 - $260.97 $26,791 - $31,577
121 Added 3.77%
3,331 $869,000
Q4 2021

Jan 10, 2022

BUY
$177.01 - $223.45 $1,770 - $2,234
10 Added 0.31%
3,210 $705,000
Q3 2021

Nov 24, 2021

BUY
$181.39 - $202.99 $453,474 - $507,475
2,500 Added 357.14%
3,200 $580,000
Q2 2021

Jul 30, 2021

SELL
$187.49 - $221.1 $35,623 - $42,009
-190 Reduced 21.35%
700 $141,000
Q1 2021

Apr 29, 2021

BUY
$207.02 - $241.31 $22,772 - $26,544
110 Added 14.1%
890 $191,000
Q4 2020

Jan 15, 2021

BUY
$207.01 - $276.09 $59,411 - $79,237
287 Added 58.22%
780 $184,000
Q3 2020

Oct 21, 2020

SELL
$255.65 - $303.1 $2,812 - $3,334
-11 Reduced 2.18%
493 $134,000
Q2 2020

Jul 10, 2020

SELL
$225.48 - $295.8 $3,833 - $5,028
-17 Reduced 3.26%
504 $146,000
Q1 2020

Apr 15, 2020

BUY
$199.77 - $247.81 $49,143 - $60,961
246 Added 89.45%
521 $124,000
Q4 2019

Jan 22, 2020

BUY
$166.71 - $223.91 $16,337 - $21,943
98 Added 55.37%
275 $60,000
Q2 2019

Aug 07, 2019

BUY
$164.61 - $190.37 $15,802 - $18,275
96 Added 118.52%
177 $32,000
Q1 2019

Apr 29, 2019

BUY
$163.73 - $194.7 $12,934 - $15,381
79 Added 3950.0%
81 $15,000
Q3 2018

Oct 30, 2018

BUY
$167.73 - $192.74 $335 - $385
2 New
2 $1,000
Q4 2017

Feb 14, 2018

SELL
$137.28 - $155.55 $2,196 - $2,488
-16 Closed
0 $0
Q3 2017

Oct 26, 2017

BUY
$148.13 - $162.24 $2,370 - $2,595
16
16 $2,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.